Siga Technologies INC Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent
Siga Technologies INC (SIGA) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent of 2.30% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost · last filed 2026-03-10
- Siga Technologies INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2025 was 2.30%, a 53.33% increase from fiscal 2024.
- Siga Technologies INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2024 was 1.50%, a 275.00% increase from fiscal 2023.
- Siga Technologies INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2023 was 0.40%.
- Siga Technologies INC effective income tax rate reconciliation, nondeductible expense, share-based payment arrangement, percent for fiscal 2015 was 0.00%.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent 12 month as first filed |
|---|---|---|
| 2025-12-31 | 2.30% 10-K · filed 2026-03-10 | |
| 2024-12-31 | 1.50% 10-K · filed 2026-03-10 | |
| 2023-12-31 | 0.40% 10-K · filed 2026-03-10 | |
| 2015-12-31 | 0.00% 10-K · filed 2016-03-04 | |
| 2014-12-31 | 0.00% 10-K · filed 2016-03-04 | |
| 2013-12-31 | -0.40% 10-K · filed 2016-03-04 | |
| 2012-12-31 | -0.80% 10-K · filed 2015-03-06 | |
| 2011-12-31 | -24.80% 10-K · filed 2014-03-10 | -7.70% 10-K · filed 2013-03-06 |
| 2010-12-31 | 0.00% 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |